[Antiastenic effect of sequential levocarnitine and acetylcarnitine therapy in patients with cardiovascular diseases].

Statsenko, M E; Turkina, S V

[Antiastenic effect of sequential levocarnitine and acetylcarnitine therapy in patients with cardiovascular diseases]. / Antiastenicheskii effekt posledovatel'noi terapii levokarnitinom i atsetilkarnitinom patsientov s serdechno-sosudistoi patologiei.

Statsenko, M E; Turkina, S V.

Affiliation

Statsenko ME; Volgograd State Medical University, Volgograd, Russia.
Turkina SV; Volgograd State Medical University, Volgograd, Russia.

Zh Nevrol Psikhiatr Im S S Korsakova ; 122(12): 95-100, 2022.

Article in Ru | MEDLINE | ID: mdl-36537638

Subject(s)

Cardiovascular Diseases; Hypertension; Humans; Acetylcarnitine/therapeutic use; Carnitine; Cardiovascular Diseases/chemically induced; Asthenia/drug therapy; Syndrome; Hypertension/drug therapy

Key words

Carnicetine; Elcar; acetylcarnitine; cardiovascular diseases; endothelial dysfunction; levocarnitine; moderate cognitive deficit

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Hypertension Limits: Humans Language: Ru Journal: Zh Nevrol Psikhiatr Im S S Korsakova Journal subject: NEUROLOGIA / PSIQUIATRIA Year: 2022 Document type: Article Affiliation country: RUSSIA

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google